Oncorhynchus keta head hydrolysate

Oncorhynchus keta head hydrolysate has been studied in 1 paper since 2026: none in people yet, 1 in animals; 1 in the past year. The research so far is in animals. The newest paper, May 19, 2026: “Sustainable Valorization of Salmon Head By-Products into Chondroitin Sulfate-Enriched Hydrolysates for Postmenopausal Osteoporosis Management”.

Intervention

1 paper studies it5 findingsUpdated

See all 1 papers on oncorhynchus keta head hydrolysate

At a glance

The findings reach mice, none yet in people. 1 lab in 1 country.

None of its findings points the other way.

Cells and mice: a single group. Worms or flies and humans: nothing yet.
  • 1 lab in 1 country
  • Funder: Korea Institute of Marine Science and Technology promotion
  • Animals1

What did studies of oncorhynchus keta head hydrolysate find?

5

Studies of oncorhynchus keta head hydrolysate measured 5 outcomes, among them bone mass, skeletal mineralization and TNFSF11.

Bone mass

upin rats1

1 study
  1. Oncorhynchus keta head hydrolysate improves bone mass in OVX rats.

    “preserved bone mass and trabecular architecture in OVX rats”

    Animalsin OVX rats

    Sustainable Valorization of Salmon Head By-Products into Chondroitin Sulfate-Enriched Hydrolysates for Postmenopausal Osteoporosis Management

    Journal of Aquatic Food Product Technology

Skeletal mineralization

upin zebrafish1

1 study
  1. Oncorhynchus keta head hydrolysate increases skeletal mineralization in zebrafish (dose-dependent (25–100 μg/mL)).

    “SBPE also significantly increased skeletal mineralization in zebrafish in adose-dependent manner (25–100 μg/mL)”

    Animals25–100 μg/mL

    Sustainable Valorization of Salmon Head By-Products into Chondroitin Sulfate-Enriched Hydrolysates for Postmenopausal Osteoporosis Management

    Journal of Aquatic Food Product Technology

TNFSF11

downin mouse cells1

1 study
  1. Oncorhynchus keta head hydrolysate decreases TNFSF11 in MC3T3-E1 osteoblasts (-11.71 ± 1.77%).

    “reduced receptor activator of nuclear factor-κB ligand (RANKL) levels by 11.71 ± 1.77%, indicating enhanced osteogenic differentiation”

    Cellsin MC3T3-E1 osteoblasts

    Sustainable Valorization of Salmon Head By-Products into Chondroitin Sulfate-Enriched Hydrolysates for Postmenopausal Osteoporosis Management

    Journal of Aquatic Food Product Technology

More on TNFSF11

TNFRSF11B

upin mouse cells1

1 study
  1. Oncorhynchus keta head hydrolysate increases TNFRSF11B in MC3T3-E1 osteoblasts (8.76 ± 1.24%).

    “elevated osteoprotegerin (OPG) expression by 8.76 ± 1.24%, and reduced receptor activator of nuclear factor-κB ligand (RANKL) levels by 11.71 ± 1.77%”

    Cellsin MC3T3-E1 osteoblasts

    Sustainable Valorization of Salmon Head By-Products into Chondroitin Sulfate-Enriched Hydrolysates for Postmenopausal Osteoporosis Management

    Journal of Aquatic Food Product Technology

More on TNFRSF11B

Alkaline phosphatase

upin mouse cells1

1 study
  1. Oncorhynchus keta head hydrolysate increases alkaline phosphatase in MC3T3-E1 osteoblasts (16 ± 2.18%).

    “In MC3T3-E1 osteoblasts, SBPE increased alkaline phosphatase (ALP) activity by 16 ± 2.18%”

    Cellsin MC3T3-E1 osteoblasts

    Sustainable Valorization of Salmon Head By-Products into Chondroitin Sulfate-Enriched Hydrolysates for Postmenopausal Osteoporosis Management

    Journal of Aquatic Food Product Technology

More on Alkaline phosphatase

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 1Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 01 paper in 12 months